兴齐眼药股价涨5.01%，浙商证券资管旗下1只基金重仓，持有3.33万股浮盈赚取12.39万元

Group 1 - The core point of the news is the performance of Xingqi Eye Pharmaceutical Co., Ltd., which saw a stock price increase of 5.01% to 78.00 CNY per share, with a trading volume of 1.249 billion CNY and a turnover rate of 8.64%, resulting in a total market capitalization of 19.137 billion CNY [1] - The company, established on March 24, 1977, and listed on December 8, 2016, specializes in the research, production, and sales of ophthalmic drugs, with its main revenue sources being eye drops (82.15%), gel/ointment (16.70%), and other products (1.15%) [1] Group 2 - From the perspective of fund holdings, a fund under Zheshang Securities Asset Management has a significant position in Xingqi Eye Pharmaceutical, with the Zheshang Huijin Transformation Driver fund (001540) holding 33,300 shares, accounting for 3.18% of the fund's net value, ranking as the ninth largest holding [2] - The Zheshang Huijin Transformation Driver fund was established on July 27, 2015, with a latest scale of 54.3128 million CNY, achieving a year-to-date return of 9.92% and a one-year return of 7.91% [2]